ID: MRFR/HC/5896-HCR | February 2021 | Region: Global | 110 pages
Preclinical imaging market is expected to grow significantly over the forecast period. It is anticipated that the market held value of USD 2.01 billion in 2017 and is projected to grow at a CAGR of 6.3% over the forecast period.
The factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical research are expected to propel the growth of the market. However, strict regulations in preclinical research and high installation and operational costs associated with preclinical imaging modalities hamper the market growth over the forecast period.
The preclinical imaging market has been segmented into modality, reagent, and region.
Based on modality, market is segmented into optical imaging systems, nuclear imaging systems, micro-MRI, micro-ultrasound, micro-CT, photoacoustic imaging system, and magnetic particle imaging systems. The optical imaging systems segment is expected to account for the largest share segment of the market in 2017.
Based on reagent, preclinical imaging market is segmented into preclinical optical imaging reagents, preclinical nuclear imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents, and preclinical CT contrast agents. The preclinical optical imaging reagents segment is expected to account for the largest share segment of the market in 2017.
The preclinical imaging market segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The market in the Americas further segmented into North America and South America, with the North American market divided into the US and Canada.
The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The preclinical imaging market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The preclinical imaging market in the Middle East & Africa segmented into the Middle East and Africa.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the preclinical imaging market owing to a well-established player, technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches.
Europe is expected to hold the second largest position in the market. The market growth in this region is attributed to increasing funding to support preclinical researches.
The preclinical imaging market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region.
The Middle East & Africa has the least share of the preclinical imaging market.
Market of Preclinical Imaging, by Modality
Market of Preclinical Imaging, by Reagent
Market of Preclinical Imaging, by Region
Market of Preclinical Imaging, by Key Players
|Market Size||2027: Significant Value|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product and Reagent|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Bruker Corporation (US), MR Solutions (UK), PerkinElmer (US), Fujifilm Holdings Corporation (Japan), Milabs B.V. (The Netherlands), Mediso Ltd. (Hungary), Miltenyi Biotec GmbH (Germany), LI-COR, Inc. (US), Aspect Imaging (Israel), Trifoil Imaging (US)|
|Key Market Opportunities||Technological advancements in the field of molecular imaging|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
The Preclinical Imaging Market is projected to grow at a 6.3% CAGR between 2018-2023.
The Americas are expected to spearhead the Preclinical Imaging Market.
Key competitors in the Preclinical Imaging Market include Trifoil Imaging (US), Aspect Imaging (Israel), Miltenyi Biotec GmbH (Germany), LI-COR, Inc. (US), Mediso Ltd. (Hungary), Milabs B.V. (The Netherlands), Fujifilm Holdings Corporation (Japan), PerkinElmer Inc. (US), MR Solutions (UK), and Bruker Corporation (US).
It finds extensive applications in cardiac imaging, orthopaedics, anatomical and functional neuroimaging, cancer research, infectious diseases, inflammation, cardiology, and neurology.
Strategies adopted by industry players to maintain dominance in the Preclinical Imaging Market include product innovations and launches, partnerships, and mergers.
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.